AE Wealth Management LLC increased its position in Linde PLC (NASDAQ:LIN – Free Report) by 14.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,635 shares of the basic materials company’s stock after acquiring an additional 2,067 shares during the quarter. AE Wealth Management LLC’s holdings in Linde were worth $7,903,000 at the end of the most recent quarter.
Several other large investors have also added to or reduced their stakes in the company. Darwin Wealth Management LLC purchased a new position in shares of Linde in the second quarter valued at about $25,000. Marquette Asset Management LLC bought a new position in Linde in the 3rd quarter worth approximately $27,000. YANKCOM Partnership grew its holdings in Linde by 195.2% during the 3rd quarter. YANKCOM Partnership now owns 62 shares of the basic materials company’s stock valued at $29,000 after buying an additional 41 shares in the last quarter. Albion Financial Group UT lifted its holdings in shares of Linde by 87.8% in the third quarter. Albion Financial Group UT now owns 77 shares of the basic materials company’s stock worth $37,000 after buying an additional 36 shares in the last quarter. Finally, Howard Hughes Medical Institute bought a new position in shares of Linde during the second quarter worth $48,000. Hedge funds and other institutional investors own 82.80% of the company’s stock.
Linde Stock Up 0.4%
NASDAQ LIN opened at $456.97 on Friday. The company has a quick ratio of 0.69, a current ratio of 0.82 and a debt-to-equity ratio of 0.46. Linde PLC has a 52 week low of $387.78 and a 52 week high of $486.38. The firm has a market capitalization of $213.38 billion, a price-to-earnings ratio of 30.61, a PEG ratio of 3.19 and a beta of 0.85. The company has a fifty day moving average of $425.82 and a two-hundred day moving average of $447.91.
Wall Street Analysts Forecast Growth
Several research analysts have commented on LIN shares. BMO Capital Markets set a $501.00 price objective on shares of Linde in a report on Wednesday, December 17th. JPMorgan Chase & Co. cut their price target on Linde from $475.00 to $455.00 and set an “overweight” rating for the company in a report on Monday, November 3rd. UBS Group reaffirmed a “buy” rating on shares of Linde in a report on Friday, December 12th. Royal Bank Of Canada cut their target price on shares of Linde from $540.00 to $490.00 and set an “outperform” rating for the company in a report on Friday, December 12th. Finally, CICC Research started coverage on shares of Linde in a research report on Wednesday, December 3rd. They set an “outperform” rating and a $510.00 price objective for the company. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Linde presently has a consensus rating of “Buy” and an average target price of $501.75.
Get Our Latest Report on Linde
Linde Profile
Linde (NASDAQ: LIN) is a multinational industrial gases and engineering company that supplies gases, related technologies and services to a wide range of industries. The company traces its current form to the 2018 combination of Germany’s Linde AG and U.S.-based Praxair, creating one of the largest global providers of industrial, specialty and medical gases. Linde’s business model centers on production, processing and distribution of gases as well as the design and construction of the plants and equipment needed to produce them.
Core products and services include atmospheric and process gases such as oxygen, nitrogen and argon; hydrogen and helium; carbon dioxide; and a portfolio of higher‑value specialty and electronic gases.
Further Reading
- Five stocks we like better than Linde
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Want to see what other hedge funds are holding LIN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Linde PLC (NASDAQ:LIN – Free Report).
Receive News & Ratings for Linde Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Linde and related companies with MarketBeat.com's FREE daily email newsletter.
